Pooled analysis of response rate and overall survival of Tyrosine Kinase inhibitor combinations in phase II clinical trials of non-small cell lung cancer
This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2024.
Prif Awdur: | Karim, Samia Binte |
---|---|
Awduron Eraill: | Azam, Faruque |
Fformat: | Traethawd Ymchwil |
Iaith: | English |
Cyhoeddwyd: |
Brac University
2024
|
Pynciau: | |
Mynediad Ar-lein: | http://hdl.handle.net/10361/23944 |
Eitemau Tebyg
-
Efficacy analysis and prediction in phase II clinical trials of non-small cell Lung Cancer
gan: Hoque, Ismoth Ara
Cyhoeddwyd: (2024) -
Effect of performance status on efficacy endpoints in phase II trials of non-small cell lung cancer
gan: Paul, Pulock
Cyhoeddwyd: (2024) -
Impact of treatment size and therapy type in phase II clinical trials of non-small cell lung cancer
gan: Rahman, Tasnim
Cyhoeddwyd: (2024) -
Efficacy analysis of tyrosine kinase inhibitor combinations in phase II clinical trials of non-small cell lung cancer
gan: Flora, Sanzida Alam
Cyhoeddwyd: (2024) -
Genetic innovations for breast cancer treatment : a review of gene therapy strategies and future implications
gan: Hasan, Sakib
Cyhoeddwyd: (2024)